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Background: SLC10A2-mediated reabsorption of bile acids at the distal end of the ileum is the first step in
enterohepatic circulation. Because bile acids act not only as detergents but also as signaling molecules in lipid
metabolism and energy production, SLC10A2 is important as the key transporter for understanding the in vivo
kinetics of bile acids. SLC10A family members and the homologous genes of various species share a highly
conserved region corresponding to Gly104–Pro142 of SLC10A2. The functional importance of this region has not
been fully elucidated.
Results: To elucidate the functional importance of this region, we previously performed mutational analysis of the
uncharged polar residues and proline in the distal one-third (Thr130–Pro142) of the highly conserved region in
mouse Slc10a2. In this study, proline and uncharged polar residues in the remaining two-thirds of this region in
mouse Slc10a2 were subjected to mutational analysis, and taurocholic acid uptake and cell surface localization were
examined. Cell surface localization of Slc10a2 is necessary for bile acid absorption. Mutants in which Asp or Leu
were substituted for Pro107 (P107N or P107L) were abundantly expressed, but their cell surface localization was
impaired. The S126A mutant was completely impaired in cellular expression. The T110A and S128A mutants
exhibited remarkably enhanced membrane expression. The S112A mutant was properly expressed at the cell
surface but transport activity was completely lost. Replacement of Tyr117 with various amino acids resulted in
reduced transport activity. The degree of reduction roughly depended on the van der Waals volume of the side
chains.
Conclusions: The functional importance of proline and uncharged polar residues in the highly conserved region of
mouse Slc10a2 was determined. This information will contribute to the design of bile acid-conjugated prodrugs for
efficient drug delivery or SLC10A2 inhibitors for hypercholesterolemia treatment.
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Bile acids are synthesized from cholesterol in the liver
and secreted into the small intestine as components of
bile for the digestion and absorption of lipids and lipid-
soluble vitamins. In addition to the detergent action of
bile acids, which aids in the digestion and absorption of
lipid and lipid-soluble nutrients by forming micelles with
biliary phospholipids and cholesterol, bile acids are now
appreciated as signaling molecules that control lipid me-
tabolism and energy production [1-6]. At the distal end
of the ileum, 95%–98% of bile acids are effectively reab-
sorbed by an ileal sodium-dependent bile acid trans-
porter (SLC10A2, also designated ASBT, ISBT, or IBAT)
and returned to the liver via portal circulation. Among
the transporters that are expressed in the liver, intestine,
and bile duct and are involved in enterohepatic circula-
tion of bile acids, SLC10A2 is the key transporter for
understanding the in vivo kinetics of bile acids given that
reabsorption of bile acids by SLC10A2 is the first step in
enterohepatic circulation. SLC10A2 is the second mem-
ber of the solute carrier family 10, and consists of 348
amino acids. SLC10A2 is expressed in the ileum, cholan-
giocytes, and kidney, and contributes to the maintenance
of the bile acid pool and cholesterol homeostasis [7-9].
Transport of bile acids by SLC10A2 is facilitated by sodium
symport in an electrogenic process with a 2:1 Na+/bile acid
stoichiometry [10]. Given that bile acids are synthesized
from cholesterol, inhibition of bile acid reabsorption via
SLC10A2 inhibition has been used as a cholesterol-
lowering therapy. Moreover, due to its high transport
capacity in the ileum, SLC10A2 is also an attractive tar-
get for the prodrug strategy to enhance drug bioavail-
ability [11,12].
The membrane topology and detailed transport mech-
anism of SLC10A2 have been studied. Hydropathy ana-
lysis and membrane insertion scanning revealed that
SLC10A2 has an extracellular N-terminus and a cyto-
plasmic C-terminus [13,14]. The exact membrane top-
ology remains controversial: in vitro translation studies
using membrane insertion scanning suggested a 9-
transmembrane (TM) topology, whereas N-glycosylation
scanning mutagenesis and dual-label epitope insertion
scanning mutagenesis support a 7-TM topology [13-19].
The recently published crystal structure of a bacterial
homolog of SLC10A2 from Neisseria meningitidis
(designated ASBTNM) supports the 9-TM topology [20].
Protein regions and amino acid residues of SLC10A2
involved in membrane trafficking, substrate recognition,
and substrate permeation have been identified. The cyto-
plasmic tail of rat Slc10a2 acts as a sorting signal for ap-
ical trafficking, and Ser335 and Thr339 phosphorylations
are crucial for apical targeting [21]. Computational ana-
lysis based on homology-modeling and remote-
threading techniques revealed that Asp282 and Leu283 ofhuman SLC10A2 are involved in hydrogen bond forma-
tion with the 12α-hydroxyl group of bile acids [19]. A
series of analyses using the substituted-cysteine accessi-
bility method revealed that in the 7-TM model TM7
(Phe287–Tyr308) lines the substrate translocation path-
way, TM4 (Ile160–Met180) forms part of the pathway,
Asp124 interacts with the 7α-hydroxyl group of bile
acids, and the extracellular loop (EL) 1 corresponding to
Val99–Ser126 acts as a Na+ sensor [22-24]. Glu261 in EL3
has also been shown to act as a Na+ sensor, and EL1 and
EL3 have been proposed to act as re-entrant loop seg-
ments [25,26]. Despite such extensive studies, the
mechanisms underlying the binding and transport of bile
acids remain unclear.
Genes homologous to the mammalian SLC10 family
are widespread in various species [25,27]. In the align-
ment of the deduced sequences of these genes, con-
served residues are scattered throughout the entire
sequences, and some of them are clustered in a region
spanning approximately 40 residues corresponding to
Gly104–Pro142 of SLC10A2 (Figure 1). The high-level
conservation indicates that this region may play an im-
portant role in substrate interaction, conformational
change necessary for function, or interaction with cellu-
lar cofactors. As mentioned above, a part of this region
corresponding to EL1 has been proposed to function as
a dynamic re-entrant loop, but the importance of this re-
gion has not yet been fully elucidated. To determine the
importance of this region, we previously performed mu-
tational analysis of the uncharged polar residues in the
distal one-third (Thr130–Pro142) of the highly conserved
region of mouse Slc10a2 (mSlc10a2) and identified resi-
dues that may be involved in substrate recognition,
transport activity, and cellular localization [28]. In this
study, we focused on the uncharged polar residues
(Thr110, Ser113, Tyr117, Ser126, and Ser128) and proline
(Pro107) in the remaining part of the highly conserved
region. The hydroxyl group of the side chains could form
hydrogen bonds with the substrate and/or other residues
and contribute to the transport process and/or formation
of higher-order structures, and proline is expected to con-
tribute to the formation of higher-order structure.
To determine the involvement of these residues in
substrate recognition, transport, and intracellular sorting
and/or stability of mSlc10a2, taurocholic acid (TCA)
transport and cell surface localization were analyzed.
Results
Wild-type mSlc10a2 and Pro107 mutants (P107N and
P107L) were stably expressed as enhanced green fluores-
cent protein (EGFP) fusion proteins in LLC-PK1 cells, and
TCA uptake and cellular localization were analyzed. Cells
expressing wild-type Slc10a2 exhibited Na+-dependent
uptake of TCA, but this transport activity was completely
A.phenanthrenivorans 117 GCCPGGTASNVVSYLAKGDVALSVAMTTVSTLIAPLLTPVL bacterium
D.proteolyticus 115 GCVPGGTASNVVTYLARGDVALSVSLTTASTLLAPLMTPLL bacterium
P.ruminicola 104 GCCPGGTASNVITYLAKGDLALSVGMTACSTLLAPVLTPLL bacterium
H.marismortui 59 GAAPGGTASNVMAYLGRGDVALSVAITTLTTLAAPIVMPAW archaeum
H.hispanica 109 GAAPGGTASNVMAYLGRGDVALSVAITTLTTLAAPIVMPAW archaeum
H.volcanii 109 GAAPGGTASNVMAYLGKGDVALSVAITTVTTLAAPLVMPAW archaeum
H.turkmenica 109 GAAPGGTASNVMTYLGRGDVALSVSITTVTTIAAPVVMPAW archaeum
M.maripaludis 114 GACPGGTASNVITYLAKGDVALSVAITTLSTLVAPLMTPIL archaeum
M.vannielii 114 GACPGGTASNVITYLAKGDVALSVAITSFSTLIAPLLTPLI archaeum
M.voltae 114 GCCPGGTASNVITYLARGDVALSVAITTVSTIIAPLITPIL archaeum
S.pseudintermedius 104 GCCPGGTSSNVISYLAKGNVPLSVTITTISTILASFMTPFL bacterium
M.elsdenii 109 GSCPSGTASNVMGFLAKADVPLSVSITTCSTLLAPIMMPFI bacterium
O.iheyensis 106 GCCPGGTASNVMTYLAKGNTALSVSVTTISTLIAPIMTPTL bacterium
G.thermoglucosidasius 106 GCCPGGTASNVMTYLAKGDTALSVAVTSVSTILAPILTPSL bacterium
ASBTNM 106 GCCPGGTASNVMTYLARGNVALSVAVTSVSTLISPLLTPAI bacterium
M.acetivorans 120 GCCPGGTASNVICYLAKGDVALSIVLTSVSTMLAFLATPFL archaeum
M.mazei 100 GCCPGGTASNVICYLAKGDVALSIVLTSVSTMIAFLATPFL archaeum
M.barkeri 104 GCCPGGTASNVISYLAKADVALSIVLTSVSTLIAFLATPFL archaeum
A.lyrata 191 GCCPGGTASNIVTYIARGNVALSVLMTAASTVSAVIMTPLL plant
A.thaliana 193 GCCPGGTASNIVTYIARGNVALSVLMTAASTVSAVIMTPLL plant
S.lycopersicum 200 GCCPGGTASNIVTYIARGNVALSVLMTAASTLSAVVMTPFL plant
R.communis 1104 GCCPGGTASNIVTYIARGNVALSVLMTAASTLTAVVMTPFL plant
59 SCCPGGTASNVVTYLARGNVALSVIMTAISTFLAVVMTPLL plant
M.truncatula 721 GCCPGGTASNIVTYLARGNVALSVVMTAASTLSAVIMTPFL plant
G.max 211 GCCPGGTASNIITYLARANVALSVIMTTASTISAMIMTPLL plant
L.interrogans 108 SCCPGGVASNVITYLAKGDLALSVSMTASSTILSVFMTPLL bacterium
N.sp.Is79A3 102 GCCPGGTASNLVSYIAKADVALSVVMTVCSTLAAVILTPVL bacterium
Z.mays 169 GCCPGGTASNVVTLVAQGDVPLSVVMTVCSTLAAVFLTPLL plant
S.bicolor 172 GCCPGGTASNVVTLVAQGDVPLSIVMTVCSTLAAVFLTPLL plant
O.sativa 60 GCCPGGTASNVVTLVAKGDVPLSIVMTVCSTLGAVFLTPLL plant
10a1_dog 97 GCSPGGTLSNVFSLAMKGDMNLSIVMTTCSTFFALGMMPLL mammal
10A1_human 97 GCSPGGNLSNVFSLAMKGDMNLSIVMTTCSTFCALGMMPLL mammal
10a1_rabbit 97 GCSPGGNMSNLFSLAVKGDMNLSIVMTTCSTFLALGMMPLL mammal
10a1_cattle 97 GCSPGGNLSNVFALAIKGDMNLSIVMTTCSTFFALGMMPLL mammal
10a1_mouse 97 GCSPGGNLSNLFTLAMKGDMNLSIVMTTCSSFTALGMMPLL mammal
10a1_rat 97 GCSPGGNLSNLFTLAMKGDMNLSIVMTTCSSFSALGMMPLL mammal
10A4_human 175 GCCPGGNLSNLMSLLVDGDMNLSIIMTISSTLLALVLMPLC mammal
10a2_chimpanzee 104 GCCPGGTASNILAYWVDGDMDLSVSMTTCSTLLALGMMPLC mammal
10A2_human 104 GCCPGGTASNILAYWVDGDMDLSVSMTTCSTLLALGMMPLC mammal
10a2_orangutan 115 GCCPGGTASNILAYWVDGDMDLSVSMTTCSTLLALGMMPLC mammal
10a2_monkey 104 GCCPGGTSSNILAYWVDGDMDLSVSMTTCSTLLALGMMPLC mammal
10a2_dog 104 GCCPGGTASNILAYWVDGDMDLSISMTTCSTLLALGMMPLC mammal
10a2_rabbit 105 GCCPGGTASNILAYWVDGDMDLSVSMTTCSTLLALGMMPLC mammal
10a2_mouse 104 GCCPGGTGSNILAYWIDGDMDLSVSMTTCSTLLALGMMPLC mammal
10a2_rat 104 GCCPGGTGSNILAYWIDGDMDLSVSMTTCSTLLALGMMPLC mammal
10a2_hamster 104 GCCPGGTASNILAYWVDGDMDLSVSMTTCSTLLALGMMPLC mammal
10a2_cattle 104 GCCPGGTASNILAYWVDGDMDLSVSMTTCSTLLALGMMPLC mammal
10a2_platypus 103 GCCPGGTASNILAYWADGDMDLSISMTTCSTLLAMGMMPLC monotreme
10a2_chicken 114 GCCPGGTASNIIAYWVDGDMDLSISMTTCSTLLAMGMMPLC bird
10a2_opossum 103 GCCPGGTASNVLAYWCDGDMDLSISMTTCSTLLALGMMPLC mammal
10a6_chimpanzee 104 GCCPGGTISNIFTFWVDGDMDLSISMTTCSTVAALGMMPLC mammal
10A6_human 104 GCCPGGTISNIFTFWVDGDMDLSISMTTCSTVAALGMMPLC mammal
10a6_monkey 104 GCCPGGTISNIFTFWVDGDMDLSISMTTCSTVAALGMMPLC mammal
10a6_dog 104 GCCPGGTISNIFTFWVDGDMDLSITMTTCSTVAALGMMPLC mammal
10a6_cattle 104 GCCPGGTVSNIFTFWVDGDMDLSISMTTCSTMAALGMMPLC mammal
10a6_mouse 104 GSCPGGTISNVLTFWVDGDMDLSISMTTCSTVAALGMMPLC mammal
10a6_rat 104 GSCPGGTVSNVLTFWVDGDMDLSISMTTCSTVAALGMMPLC mammal
10a6_platypus 214 GCCPGGTISNIFTYWVDGDMDLSISLTTCSTVAALGLLPLC monotreme
76 GCTPGGTTSNLLTYYAKGDVALSISMTITSTILATVMMPFL bacterium
10A3_human 262 CSSPGGGGSYLFSLLLGGDVTLAISMTFLSTVAATGFLPLS mammal
10A5_human 213 CTCPGGGGGYLFALLLDGDFTLAILMTCTSTLLALIMMPVN mammal
consensus  ...*.*.............. *.. .*........ ..*.. 
Figure 1 Alignment of amino acid sequences of SLC10A family members and related proteins. The amino acid sequences of 10 of the
related genes from bacteria, archaea, and plants that yielded the highest score by a BLAST search using the amino acid sequence corresponding
to Gly104–Pro142 of mouse Slc10a2 (mSlc10a2) as a query sequence and the amino acid sequence of ASBTNM were compared with the amino acid
sequences of SLC10A family members using the ClustalW software, and shading was rendered by the BoxShade program (http://www.ch.embnet.
org/software/BOX_form.html). The alignments of the region corresponding to the query sequence are shown. The ASBTNM and mSlc10a2
sequences are boxed and the residues subjected to mutational analysis in this study and residues that have been reported to bind sodium via
their side chains [20] are indicated by arrowheads and circles, respectively.
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(Figure 2A). Western blot analysis of whole cell lysates
revealed that wild-type and mutant mSlc10a2 were abun-
dantly expressed as 55-kDa bands, and an additional band
with a lower migration rate at approximately 75 kDa was
observed only in the wild type (Figure 2B, left panel).
Because the latter band is considered to represent a fully
glycosylated protein that is localized to the plasma mem-
brane, we concluded that the mutant Slc10a2 proteins
were likely detained in the endoplasmic reticulum (ER)
and did not reach the cell surface. This was confirmed by
analyzing plasma membrane proteins (Figure 2B, right
panel). The glycosylated form was detected only in the
wild-type plasma membrane fraction.Next, we examined the transient expression of wild-
type mSlc10a2 and uncharged polar residue mutants
(T110A, S112A, Y117F, S126A, and S128A) in COS-7
cells by western blot analysis (Figure 3A). Wild-type
mSlc10a2 and all the mutants except S126A were
expressed as 55-kDa proteins. A broad band ranging
from 60–80 kDa, the fully glycosylated form, was also
detected in each lane.
To evaluate the ability of the mutants to transport bile
acids, TCA uptake by the wild-type and mutant
mSlc10a2 was compared (Figure 3B). Because cellular
expression of S126A was not detected, this mutant was
omitted from further analysis. The S128A mutant exhib-



















































Figure 2 Taurocholic acid (TCA) uptake and cellular localization
of wild-type and Pro107 mutant Slc10a2 in stably transfected
LLC-PK1 cells. A, Untransfected or stably transfected LLC-PK1 cells
were incubated with 0.1 μM [G-3H]TCA (44.03 GBq/mmol; Perkin-
Elmer) in the presence of 100 mM NaCl (shaded columns) or
100 mM choline chloride (open columns) at 37°C for 1 min. Each
column and error bar represents the mean and standard error (SE)
of 3 independent experiments, respectively. B, Whole cell lysates
(left panel) and plasma membrane fractions of untransfected or
stably transfected LLC-PK1 cells were divided into 2 equal parts and
subjected to 12.5% SDS-polyacrylamide gel electrophoresis (PAGE).
Western blotting was performed using anti-green fluorescent
protein (GFP) and anti-calnexin (endoplasmic reticulum marker)
antibodies. Filled and open arrowheads indicate fully glycosylated
and unglycosylated forms, respectively. Numbers denote molecular
weight markers.
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higher than that of wild type. TCA uptake by the Y117F
mutant was approximately half that by the wild type, but
the difference was not statistically significant. S112A did
not exhibit Na+-dependent TCA uptake.
The kinetics of TCA transport by the wild type and
the 3 functional mutants were examined (Figure 3C and
Table 1). The Vmax of Y117F was approximately half that
of the wild type, and those of T110A and S128A were
2.5- and 5-fold higher than that of the wild type, respect-
ively; interestingly, the Km values of the 3 mutants were
comparable to that of the wild type, suggesting that the
differences in the apparent TCA transport activities of
the polar residue mutants were not due to altered affin-
ity for TCA.
The cellular localization of the expressed transporters
was investigated by cell surface biotinylation (Figure 3D).
The fully glycosylated form was predominantly detected
in the biotinylated fraction. Membrane expression of
Y117F was similar to that of wild type, and the membrane
expression of T110A and S128A was significantly higher
than that of wild type, suggesting that removal of the polarhydroxyl group from Thr110 and Ser128 improved mem-
brane sorting and/or stability of mSlc10a2. Although
S112A was a loss-of-function mutation, membrane
expression of the mutant was clearly detected, indicating
that Ser112 is critical for the activity of mSlc10a2.
To compare the activities of the mutant transporters,
the Na+-dependent TCA uptake by wild-type and mu-
tant mSlc10a2 was normalized to the cell surface expres-
sion of the corresponding proteins (Figure 3E). The
normalized Vmax of the T110A mutant (1600 [70]
pmol·mg protein–1·min–1) was similar to that of the wild
type (1620 [50] pmol·mg protein–1·min–1), indicating
that the difference in the apparent TCA transport activ-
ity of this mutant was mainly due to the different level
of its expression at the cell surface. By contrast, the ap-
parently higher activity of S128A could not be explained
by abundant membrane expression because the normal-
ized Vmax of the S128A mutant (2410 [100] pmol·mg
protein–1·min–1) was remarkably higher than that of wild
type. The normalized Vmax value of the Y117F mutant
(1170 [90] pmol·mg protein–1·min–1) was lower than
that of wild type.
The Y117C mutation in human SLC10A2 has been
reported to be a loss-of-function mutation due to its
impaired membrane expression [23]. This is in striking
contrast to our finding that the Y117F mutant of
mSlc10a2 was properly expressed on the plasma mem-
brane and that transport activity was preserved even
though its apparent activity was lower. Because the Tyr
to Phe mutation used in the present study removed only
the polar hydroxyl group from the benzene ring of
the side chain, we infer that what is important at this
position is not polarity but the bulkiness required for
higher-order structure or stability of SLC10A2/Slc10a2.
The complete conservation of bulky residues, i.e., Tyr,
Phe, or Leu, at this position in the related genes (Figure 1)
supports this view. Therefore, we next examined the cell
surface expression and transport activities of mSlc10a2
mutants in which various residues were substituted for
Tyr117. For this purpose, a T7 tag was attached at the
N-terminus of mSlc10a2, which is exposed on the cell
surface. Western blot analysis revealed that the wild-type
and Tyr117 mutants were expressed as 40-kDa bands;
additional bands with lower migration rates, ranging from
50–60 kDa, were also detected in each lane, indicating
that all the Tyr117 mutants as well as the wild type were
properly expressed on the plasma membrane (Figure 4A).
Cell surface expression was confirmed with immuno-
fluorescence. Under nonpermeabilized conditions, the
plasma membrane was predominantly stained, whereas
additional intracellular compartments were also stained
under permeabilized conditions (Figure 5). Cell surface
expression levels were examined by surface enzyme-linked

















































































































































































































Figure 3 (See legend on next page.)
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Figure 3 Transient expression of wild-type and uncharged polar residue mutants of mSlc10a2 and cell surface biotinylation. A, Twenty
micrograms of whole cell lysates of COS-7 cells transiently expressing wild-type or mutant mSlc10a2 fused with EGFP were subjected to 7.5%
SDS-PAGE and western blotting was performed using anti-GFP antibody. Consistency of protein loading was confirmed by Ponceau S staining of
the blotted PVDF membrane (not shown). B, COS-7 cells transiently expressing wild-type or mutant mSlc10a2 were incubated with 0.1 μM 3H-
TCA (185 GBq/mmol; Perkin-Elmer) for 5 min in the presence of 100 mM NaCl (shaded columns) or 100 mM choline chloride (open columns).
Each column and error bar represents the mean and SE of 3 independent experiments, respectively. *, Uptake in the presence of NaCl is
significantly higher than that in the presence of choline chloride (p < 0.05); #, Na+-dependent uptake is significantly different from that of wild-
type Slc10a2 (p < 0.05). C, Na+-dependent uptake of TCA was calculated by subtracting the uptake in the presence of 100 mM choline chloride
from that in the presence of 100 mM NaCl. Data represent the mean and SE of 3 independent experiments. D, Left panel, Whole cell lysates and
biotinylated fractions of COS-7 cells transiently expressing wild-type or mutant mSlc10a2 were subjected to western blot analysis. The image is
representative of 3 independent experiments. The graph shows the densitometry of bands ranging from 65–90 kDa expressed as the mean and
SE of 3 independent experiments. Right panel, Western blot analysis of whole cell lysates and biotinylated fractions of untransfected (ut) and
empty vector-transfected (v) COS-7 cells. Because the migration rate of EGFP (26.9 kDa) encoded by empty vector is smaller than that of EGFP-
fused mSlc10a2, proteins were resolved on a higher concentration (12.5%) of SDS-polyacrylamide gel. E, Na+-dependent TCA uptake by wild-type
and mutant mSlc10a2 were normalized to their cell surface expression.
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wild type (Figure 4B). Na+-dependent TCA uptake by all
the Tyr117 mutants, except Y117F, was significantly lower
than that of wild type (Figure 4C). Next, we analyzed the
kinetic properties of the Y117S mutant, which exhibited
remarkably reduced TCA uptake compared to that of wild
type. The Km for Na
+-dependent TCA uptake by the
Y117S mutant (19.1 [2.4] μM) was similar to that of wild
type (19.8 [4.7] μM), whereas the Vmax of Y117S (216 [10]
pmol·mg protein–1·min–1) was remarkably lower than that
of wild type (2965 [263] pmol·mg protein–1·min–1)
(Figure 4D). These results indicate that the apparently
decreased activities of the Tyr117 mutants are probably
due to their decreased molecular activities.
Discussion
Optimal function of SLC10A2 is required for bile acid
reabsorption in the ileum. Impairment of this function
not only affects cholesterol homeostasis but may also in-
crease the possibility of colorectal tumorigenesis due to
increased flow of bile acids into the large intestine. In-
deed, prevention of bile acid reabsorption by surgical re-
moval of the ileum increased colonic tumorigenesis in
rats fed deoxycholic acid [29]. The C to T polymorphism
at codon 169 of the human SLC10A2 gene is associated
with colorectal adenomas, indicating the role of bile acids
in the etiology of this disease [30]. A genetic polymorph-
ism associated with primary bile acid malabsorptionTable 1 Kinetic values for taurocholic acid transport by
wild-type and polar-residue mutant mouse Slc10a2
proteins
Km (μM) Vmax (pmol·mg protein
–1·min–1)
Wild type 24.0 (2.0) 1620 (50)
T110A 20.2 (2.3) 4010 (170)
Y117F 20.7 (4.1) 806 (61)
S128A 42.0 (3.7) 7930 (340)
Data are expressed as mean (standard error).(PBAM) or idiopathic intestinal bile acid malabsorption
(IBAM) has been identified, and mutations that abolish
transport function (L243P and T262M) and a haplotype
block linked to reduced expression have been reported for
human SLC10A2 [31,32]. This polymorphism has not
been mapped in the highly conserved region, and the
importance of the cluster of conserved residues has not
yet been fully clarified. Toward the end of the study
presented here, the crystal structure of ASBTNM was
reported, and some of the residues were indicated to form
a part of the Na+-binding pocket [20].
We have previously reported the importance of Pro142,
which is located at the distal end of the highly conserved
region [28]. Substitution of Pro142 with Val completely
impaired cell surface localization of mSlc10a2. This is
consistent with our results from the mutational analysis
of Pro107 showing that Asn or Leu substitution for
Pro107 impaired cell surface expression of mSlc10a2,
resulting in the loss of transport activity. In the 9-TM
model, Pro107 is located in the middle of TM3. Proline
acts as a “helix breaker” due to its inability to form
hydrogen bonds with neighboring residues; therefore,
TM3 would be bent at Pro107, forming hydrophobic and
amphipathic half helices. Indeed, the crystal structure of
ASBTNM suggests that the helix that contains Pro
107 is
broken precisely at this residue [20]. In the 7-TM model,
Pro107 is located in the EL between TM2 and TM3. In
the ER, immediately after the synthesis of the nascent
protein, this loop faces the lumen. Substitution of Pro107
with Asn or Leu may have introduced an interaction of
this loop with other ELs or ER factors, resulting in de-
tention of the mutant Slc10a2. In either case, failure of
the Pro107 mutants to localize to the cell surface suggests
that the peculiar nature of proline, an imino acid, and
not the hydrophobicity or bulkiness of the side chain is
important for intracellular sorting. Given that proline at
this position is highly conserved in the related proteins,
it is expected to be crucial for function through correct
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Figure 4 Expression and transport activities of Tyr117 mutants. A, COS-7 cells were transiently transfected with expression vectors for T7-tagged
wild-type or mutant mSlc10a2. Whole cell lysates were examined by western blotting using anti-T7 antibody (upper). Whole cell lysate of
untransfected cells was loaded as a control (ctrl). Filled and open arrows indicate core-glycosylated and fully glycosylated forms of T7-mSlc10a2,
respectively. T7-tag constructs yield lower levels of the fully glycosylated form compared to EGFP-fusion constructs. Circles indicate apparently
nonspecific bands. The membrane was stripped and reprobed with anti-β-actin antibody (lower). B, Cell surface expression was measured by surface
enzyme-linked immunosorbent assay. Data are expressed as mean and SE of a sextuplicate experiment. C, COS-7 cells transiently expressing wild-type
or mutant mSlc10a2 were incubated with 0.02 μM 3H-TCA (370 GBq/mmol; American Radiolabeled Chemicals) for 5 min in the presence of 100 mM
NaCl or 100 mM choline chloride, and Na+-dependent uptake was calculated by subtracting the uptake in the presence of 100 mM choline chloride
from that in the presence of 100 mM NaCl. Na+-dependent uptake data are expressed as mean and SE of 3 independent experiments. #, Na
+-dependent uptake is significantly different from that of wild-type Slc10a2 (p < 0.05). D, Kinetic analysis of Na+-dependent TCA transport by wild-type
and Y117S. Data are expressed as the mean and SE of 3 independent experiments. Circles, wild type; squares, Y117S. E, Na+-dependent TCA uptake by
the wild-type mSlc10a2 and Tyr117 mutants are plotted against the van der Waals volume of the residue at position 117.
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stability of human SLC10A2 because replacement of Ser112
with Cys completely abolished expression [23]. In this
study, however, Ala substitution of Ser112 did not impair
membrane expression of mSlc10a2, whereas TCAtransport activity was completely lost. This suggests that
Ser112 is not critical for mSlc10a2 expression but is
essential for TCA transport activity. Based on the crystal
structure of ASBTNM, Ser
112 of mSlc10a2 is thought to














nonpermeabilized permeabilized nonpermeabilized permeabilized
Figure 5 Immunofluorescence microscopy of wild-type and Tyr117 mutant mSlc10a2. COS-7 cells transiently expressing T7-tagged
mSlc10a2 proteins were incubated with anti-T7 antibody under nonpermeabilized (left panel) or permeabilized (right panel) conditions, followed
by fluorescein-conjugated secondary antibody. The merged image of mSlc10a2 immunofluorescence (green) and nuclear staining (blue)
is shown.
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(Figure 1), suggesting that this residue is also critical
in all the other members.
Expression of the S126A mutant was undetectable
even in whole cell lysates. This is consistent with a pre-
vious report showing the failure of expression of the
human SLC10A2 S126C mutant [23]. This residue has
been suggested to bind Na+ [20], and it is likely that
Ser126 plays an important role in the other members as
well, given that this residue is conserved in all the genes
except those encoding SLC10A3 and SLC10A5.
Because Thr110 and Ser128 are not conserved in the
related proteins, particularly in the Na+-dependent bile
acid transporter SLC10A1 (also designated NTCP or
BSBT), which is expressed on the sinusoidal membrane of
hepatocytes, it is unlikely that these residues are involvedin the interaction with bile acids. The apparently higher
membrane expression of the T110A and S128A mutants
suggests that these residues may be involved in the nega-
tive regulation of stability or intracellular sorting via
formation of higher-order structures or interaction with
cellular cofactors.
The Phe substitution for Tyr117, which removes a
polar hydroxyl group, reduced the transport activity of
mSlc10a2; however, substrate affinity was not affected.
This result was inconsistent with the previous finding
that the Y117C mutation completely impaired mem-
brane expression of human SLC10A2. To resolve this
discrepancy, we replaced Tyr117 of mSlc10a2 with vari-
ous amino acids and examined cellular localization and
transport activities. None of the residues substituted for
Tyr117 affected cell surface expression of mSlc10a2;
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The reason for the contradiction between our results
and the results of the Y117C mutation in human
SLC10A2 is not clear, but a difference in the amino acid
sequence context between mSlc10a2 and the human
counterpart or undefined differences in experimental
conditions may have affected the results. The relation-
ship between the apparent activities and physicochemical
properties of the residues were analyzed. Hydrophobicity
and polarity did not correlate with activity (data not
shown), but a weak correlation was observed between the
van der Waals volumes of the residues and the activities
of the mutants (Figure 4E). However, the correlation was
not statistically significant (p = 0.0705), because the
Y117W mutant with the bulkiest side chain exhibited
moderate activity, and substitution with Ile and Leu,
which have relatively bulky side chains, elicited low trans-
port activities, suggesting that the volume of the side
chain as well as its shape are important at this position.
Although the crystal structure of ASBTNM indicated that
Tyr117 does not directly interact with Na+ or taurocholate,
it is obvious that this residue is important for the molecu-
lar activity of the transporter. Tyr117 may be involved in
conformational changes during TCA transport.
Conclusions
In this study, residues critical for transport activity, ex-
pression, and stability and/or intracellular trafficking,
but not substrate recognition, were identified within the
proximal two-thirds of the highly conserved region.
Functionally important residues are clustered in the
highly conserved region. Due to the specific and high
transport capacity of SLC10A2 in the ileum, bioavailabil-
ity of drugs may be enhanced by designing them as bile
acid-conjugated prodrugs. The information on function-
ally critical residues will contribute to the design of pro-
drugs for efficient drug delivery and SLC10A2 inhibitors
for treatment of hypercholesterolemia.
Methods
Materials
[G-3H]TCA was purchased from Perkin-Elmer (Waltham,
MA) and American Radiolabeled Chemicals (St. Louis,
MO). Unlabeled sodium taurocholate was purchased from
Nacalai Tesque (Kyoto, Japan). The Cell Surface Protein
Isolation Kit, which included sulfosuccinimidyl 2-(biotina-
mido)ethyl-1,3-dithiopropionate (sulfo-NHS-SS-biotin),
was purchased from Pierce (Rockford, IL). Streptavidin
agarose was purchased from Merck (Darmstadt, Germany).
The anti-green fluorescent protein (GFP) monoclonal anti-
body was purchased from Nacalai Tesque. The anti-T7
tag monoclonal antibody was purchased from Merck.
The anti-calnexin rabbit polyclonal antibody was from
Novus Biologicals (Littleton, CO). Secondary antibodies(horseradish peroxidase (HRP)-conjugated anti-mouse,
anti-rat, and anti-rabbit IgG) were purchased from
Nacalai Tesque. Fluorescein-labeled anti-mouse second-
ary antibody was purchased from Kirkegaard & Perry
Laboratories (Gaithersburg, MD). The cloning vector
pUC119 was purchased from Takara Bio (Shiga, Japan).
The mammalian expression vectors pEGFP-N1 and
pZeoSV2(+) were purchased from Clontech (Shiga,
Japan) and Invitrogen (Tokyo, Japan), respectively. Mu-
tagenic oligonucleotide primers for site-directed muta-
genesis were custom synthesized and purchased from
Invitrogen. Site-directed mutagenesis of Pro107 and un-
charged polar residues was performed using the Quick-
change II Site-Directed Mutagenesis Kit purchased from
Stratagene (La Jolla, CA). Site-directed mutagenesis of
Tyr117 was performed using the PrimeSTAR Mutagenesis
Basal Kit purchased from Takara Bio.
Cell culture
The simian kidney fibroblast cell line COS-7 was grown
in Dulbecco’s modified Eagle’s medium supplemented
with 10% fetal bovine serum (FBS), 4 mM L-Gln, and
0.1 mg/mL kanamycin sulfate. The porcine kidney cell
line LLC-PK1 was grown in M199 medium supplemen-
ted with 10% FBS and 0.1 mg/mL kanamycin. Cells were
cultured at 37°C in a humidified atmosphere of 5% CO2.
Construction of expression vectors
The mSlc10a2 cDNA encoding the full-length transporter
(molecular weight, 38 kDa) was cloned in our laboratory
[33]. Wild-type or mutant mSlc10a2 was expressed as a
fusion protein with enhanced green fluorescent protein
(EGFP) or a T7 tag. The expression vectors for EGFP-
fused mSlc10a2 were constructed as previously reported
[28]. To construct the expression vector for T7-tagged
mSlc10a2, an EcoRI recognition site was introduced at the
start codon by polymerase chain reaction (PCR) using the
50 primer 50-CGAATTCAGATGGATAACTCCTCTGTC
TG-30, in which the underlined portion represents the
start codon, and the 30 primer 50-GAAGGATCCCCATGG
TCTCTTTATATGTCC-30 corresponding to nucleotides
178–207 of the coding region in which a BamHI site was
introduced without affecting the amino acid sequence.
The amplified fragment was cloned into pUC119 and
sequenced to confirm the absence of PCR-derived muta-
tions. The EcoRI-BamHI fragment obtained from the
amplified clone and the remaining part of the coding re-
gion were cloned into pZeoSV2(+), and a double-stranded
synthetic oligonucleotide encoding the T7 tag next to the
start codon (top strand, 50-CTAGCATGGGGATGGCT
AGCATGACTGGTGGACAACAGATGGGTGG-30; bot-
tom strand, 50-AATTCCACCCATCTGTTGTCCACCA
GTCATGCTAGCCATCCCCATG-30, where the under-
lined portions represent the T7 tag) was inserted at the
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designated pSV40-T7-mSLC10A2.
Site-directed mutagenesis
An EcoRI-BamHI restriction fragment corresponding to
nucleotides 1–589 of the coding region of mSlc10a2
cDNA was cloned into pUC119, and site-directed muta-
genesis was performed according to the manufacturer’s
instructions. Mutagenesis of Pro107 was performed using
synthetic double-stranded primers (sense primer, 50-G
CTAATTATGGGTTGCTGCNNNGGAGGAACTGGC
TCC-30; and antisense primer, 50-GGAGCCAGTTCC
TCCNNNGCAGCAACCCATAATTAGC-30; where the
underlined portions represent the Pro107 codon, and N
indicates a randomized nucleotide). Following nucleotide
sequence analysis, 2 clones with Asn and Leu substitu-
tions for Pro107 were obtained. Mutagenesis of uncharged
polar residues was performed using synthetic double-
stranded primers (T110A sense primer, 50-GCTGCCCTG
GAGGAGCTGGCTCCAATATCC-30, and antisense pri-
mer, 50-GGATATTGGAGCCAGCTCCTCCAGGGCAG
C-30; S112A sense primer, 50-CTGGAGGAACTGGCGCC
AATATCCTGGCC-30, and antisense primer, 50-GGCCA
GGATATTGGCGCCAGTTCCTCCAG-30; Y117F sense
primer, 50-GCTCCAATATCCTGGCCTTTTGGATAGA
TGGCG-30, and antisense primer, 50-CGCCATCTATCCA
AAAGGCCAGGATATTGGAGC-30; S126A sense primer,
50-GGCGACATGGACCTCGCTGTTAGCATGACCACT
TGC-30, and antisense primer, 50-GCAAGTGGTCATG
CTAACAGCGAGGTCCATGTCGCC-30; S128A sense
primer, 50-CATGGACCTCAGTGTTGCCATGACCACT
TGCTCCAC-30, and antisense primer, 50-GTGGAGCA
AGTGGTCATGGCAACACTGAGGTCCATG-30; where
the underlined portions represent the target codons). Mu-
tagenesis of Tyr117 was performed using synthetic double-
stranded primers (sense primer, 50-CTGGCCTATTGGAT
AGATGGCGACAT-30; and antisense primer, 50-TATCCA
ATAGGCCAGGATATTGGAGCC-30; the underlined
portions represent the Tyr117 codon of wild-type mSlc10-
a2, and this codon was replaced with the following
sequences: Y117A, GCT; Y117C, TGT; Y117H, CAT;
Y117I, ATT; Y117L, CTT; Y117S, TCT; Y117T, ACT;
Y117V, GTT; Y117W, TGG). All the mutations were veri-
fied by DNA sequencing. The corresponding segment of
the expression vector was replaced with the restriction
fragment containing the expected mutation.
Transient expression and TCA uptake
On the day before transfection, 2.4 × 105 COS-7 cells were
seeded in a 3.5-cm dish. The cells were transfected with
appropriate expression vectors using Lipofectamine and
Plus reagent (both purchased from Invitrogen), according
to the manufacturer’s instructions. Two days after trans-
fection, uptake of 3H-TCA was measured as previouslydescribed with slight modifications [34]. The cells were
washed twice with a wash buffer (10 mM Tris-HCl, pH
7.4, 200 mM mannitol), and were then covered with 1 mL
of uptake buffer (10 mM Tris-HCl, pH 7.4, 100 mM NaCl
or choline chloride, 3 mM K2HPO4) containing the indi-
cated concentration of 3H-TCA and incubated at 37°C.
The reaction was stopped by washing cells twice with 1
mL of ice-cold wash buffer, and cells were lysed in 1 mL
of 0.2 M NaOH. Cell-associated radioactivity was mea-
sured using a liquid scintillation counter (Perkin-Elmer)
and normalized to the total protein content determined
using the Bradford method with bovine serum albumin as
a concentration standard. For quantitative transport ana-
lysis, TCA was used at a concentration range much lower
than the critical micellar concentration.
Apparent Km and Vmax values for TCA uptake were
determined by measuring the initial rates of uptake at
various concentrations of taurocholate. The TCA con-
centration was adjusted by adding unlabeled TCA. The
data were fitted to the Michaelis-Menten equation by
nonlinear regression using the KaleidaGraph 4.0 soft-
ware (Synergy Software, Reading, PA).
Cell surface biotinylation
Biotinylation of cell surface proteins was performed
using the Cell Surface Protein Isolation Kit according to
the manufacturer’s instructions with modifications.
COS-7 cells were transfected with pZmISBT-EGFP2, as
described above, and incubated for 2 days. The cells
were washed twice with ice-cold phosphate-buffered sa-
line (PBS; 0.1 M sodium phosphate, 0.15 M NaCl, pH
7.2) and then covered with a membrane-impermeable
biotinylating reagent (2.0 mL of 1.5 mg/mL sulfo-NHS-
SS-biotin dissolved in ice-cold PBS) at 4°C for 30 min
with constant agitation. The reaction was stopped by
adding 100 μL of quenching solution (provided as a
component of the kit) and washed with Tris-buffered sa-
line (0.025 M Tris-HCl, 0.15 M NaCl, pH 7.2). The cells
were then covered with 700 μL of lysis buffer (150 mM
NaCl, 1 mM EDTA, 0.1% SDS, 1% Triton X-100, 10 mM
Tris-HCl, pH 7.4) supplemented with protease inhibitors
(2 mM phenylmethylsufonyl fluoride, 0.022 trypsin in-
hibitor units/mL aprotinin, 5 μg/mL leupeptin, 0.1 μg/
mL pepstatin) at 4°C for 1 h with constant agitation.
The lysate was centrifuged at 13,000 rpm at 4°C for 10
min, and 600 μL of the supernatant was collected. The
supernatant was incubated with 40 μL of 50% (vol/vol)
streptavidin-agarose beads for 1 h with constant agita-
tion. The mixture was centrifuged at 13,000 rpm for 2
min, and the supernatant was discarded. The beads were
washed 4 times with ice-cold lysis buffer and suspended
in 20 μL of 2 × SDS sample buffer (30% glycerol, 1%
SDS, 0.093 g/mL DTT, 0.12 mg/mL bromophenol blue,
0.35 M Tris-HCl, pH 6.8). Ten microliters of the
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electrophoresis, and western blotting was performed
using anti-GFP antibody. The blots were then immersed
in 0.2 M NaOH for 5 min to remove antibodies, and
washed with distilled water for 5 min. The blots were
reprobed with anti-calnexin antibody. The relative inten-
sities of the protein bands were analyzed using Image J
software (http://rsb.info.nih.gov/ij/).
Plasma membrane fractionation
The plasma membrane fraction was extracted from cells
cultured in a 10-cm dish using the Plasma Membrane
Protein Extraction Kit (Biovision, Milpitas, CA), according
to the manufacturer’s instructions.
Immunofluorescence microscopy and surface ELISA
COS-7 cells were transfected with pSV40-T7-mSLC10A2.
Two days after transfection, the cells were washed 3 times
with PBS and incubated with 4% paraformaldehyde
dissolved in PBS for 20 min at room temperature. The
cells were then washed 3 times with PBS. For immuno-
fluorescence under permeabilized conditions, the cells
were incubated with 0.2% Triton X-100 for 20 min and
blocked with 1% BSA in PBS for 30 min at room
temperature. For nonpermeabilized conditions, incubation
with Triton X-100 was omitted. The cells were incubated
with anti-T7 tag monoclonal antibody at 1/2000 dilution
for 30 min at room temperature. The cells were washed 3
times with PBS and incubated with fluorescein-conjugated
anti-mouse antibody at 1/500 dilution for 1 h in the dark.
The cells were stained with 10 μg/mL Hoechst 33342 for
5 min and washed 3 times with PBS in the dark. The cells
were examined under a microscope (Axio Imager M1;
Carl Zeiss, Tokyo, Japan), and images were captured using
a digital camera (AxioCam MRm; Carl Zeiss). For surface
ELISA, the cells were incubated with HRP-conjugated
anti-T7 tag monoclonal antibody at 1/2000 dilution for
1 h at room temperature. The cells were washed 3 times
with PBS, and incubated with SuperSignal ELISA Femto
Maximum Sensitivity Substrate (Pierce) for 1 min at room
temperature. Luminescence was measured using a plate
reader (2030 ARVO X3; PerkinElmer).
Alignment of amino acid sequences
The nucleotide sequences of the related genes were
retrieved by a BLAST search (tblastn program provided
at http://blast.ncbi.nlm.nih.gov/) using the amino acid
sequence “GCCPGGTGSNILAYWIDGDMDLSVSMTT
CSTLLALGMMP” corresponding to Gly104–Pro142 of
mouse Slc10a2 (mSlc10a2) as a query sequence. The
deduced amino acid sequences of 10 of the identified
genes from bacteria, archaea, and plants that yielded the
highest score and the amino acid sequence of ASBTNM
were compared with the amino acid sequences of SLC10Afamily members using the ClustalW software. The amino
acid sequences were deduced from GenBank nucleotide
sequences with the following accession numbers: Arthro-
bacter phenanthrenivorans, [CP002379]; Deinococcus pro-
teolyticus, [CP002537]; Prevotella ruminicola, [CP002006];
Haloarcula marismortui, [AY596296]; Haloarcula hispa-
nica, [CP002923]; Haloferax volcanii, [CP001956]; Halo-
terrigena turkmenica, [CP001860]; Methanococcus
maripaludis, [CP000609]; Methanococcus vannielii,
[CP000742]; Methanococcus voltae, [CP002057]; Staphylo-
coccus pseudintermedius, [CP002439]; Megasphaera elsde-
nii, [HE576794]; Oceanobacillus iheyensis, [BA000028];
Geobacillus thermoglucosidasius, [CP002835]; Methano-
sarcina acetivorans, [AE010299]; Methanosarcina mazei,
[AE008384]; Methanosarcina barkeri, [CP000099]; Arabi-
dopsis lyrata, [XM_002889153]; Arabidopsis thaliana,
[BX816582]; Solanum lycopersicum, [AK320352]; Ricinus
communis, [XM_002531199]; Selaginella moellendorffii,
[FJ51633]; Medicago truncatula, [XM_003638354]; Gly-
cine max, [XM_003543135]; Leptospira interrogans,
[AE010301]; Nitrosomonas sp. Is79A3, [CP002876]; Zea
mays, [NM_001158879]; Sorghum bicolor, [XM_00244
2850]; Oryza sativa, [NM_001189880]; Leptospira biflexa,
[CP000786]; SLC10A1/Slc10a1, dog, [XM_537494];
human, [NM_003049]; rabbit, [NM_001082768]; cattle,
[BC105471]; mouse, [NM_011387]; rat, [NM_017047];
SLC10A2/Slc10a2, chimpanzee, [XM_522716]; human,
[NM_000452]; orangutan, [NM_001131608]; Macaca
mulatta (rhesus monkey), [XM_001095212]; dog, [NM_
001002968]; rabbit, [NM_001082764]; mouse, [NM_
011388]; rat, [NM_017222]; hamster, [NM_001246820];
cattle, [XM_604179]; platypus, [XM_001513315], chicken,
[XM_425589]; opossum, [XM_001376304]; human SLC
10A3, [NM_019848]; SLC10A4, [NM_152679]; SLC10A5,
[NM_001010893]; SLC10A6/Slc10a6, chimpanzee, [XM_
526626]; human, [NM_197965]; monkey, [XM_00109
2284]; dog, [XM_846210]; cattle, [NM_001081738];
mouse, [NM_029415]; rat, [NM_198049]; platypus,
[XM_001515822]. The amino acid sequence of ASBTNM
was obtained from UniProt [Q9K0A9].Statistical analysis
TCA uptake and biotinylation results were analyzed by
Dunnett’s test and Student’s t-test using the JMP soft-
ware (SAS Institute, Tokyo, Japan).Abbreviations
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